Filing Details

Accession Number:
0001274644-16-000092
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-19 08:14:06
Reporting Period:
2016-01-15
Filing Date:
2016-01-19
Accepted Time:
2016-01-19 08:14:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1274644 Ocera Therapeutics Inc. OCRX Pharmaceutical Preparations (2834) 631192270
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1551965 Gaurav Aggarwal C/O Ocera Therapeutics, Inc.
525 University Avenue, Suite 610
Palo Alto CA 94301
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-01-15 10,000 $2.15 20,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents the weighted average price for the shares. The shares were purchased at prices ranging from $2.11 per share to $2.21 per share.
  2. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.